Despite intensive efforts, there are currently no disease-modifying treatments or preventive strategies for AD.

Jan 24, 2023 · Funded by the Marie Skłodowska-Curie Actions programme, the BBDiag project aims to address this limitation by identifying AD biomarkers and developing specific detection …

BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges. It brings together leading academic and industrial …

Jan 1, 2017 · BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges. It brings together leading academic …

Dec 7, 2020 · Resting-state electroencephalography (rsEEG) provide topographic markers useful to assess the neurophysiological changes of the brain that correlate with the cognitive decline …

Jun 1, 2020 · Latest findings suggest EEG rhythms analysis as a valid screening tool to predict AD conversion. Alzheimer’s disease (AD) is the most common neurodegenerative disease …

Blood Biomarker-based Diagnostic Tools for Early-stage Alzheimer鈥檚 Disease responds to challenges in early stage diagnosis of AD and timely sets up an ETN with the required …

1 Supervisor and Early Stage Researcher's project leader in the Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer's Disease (BBDiag) project (HORIZON 2020 Marie …

Cerebrospinal fluid (CSF) tests have the ability to identify earlier stages with the help of certain biomarkers but large scale use is often limited by invasive CSF collection protocols. This study …

BBDiag responds to such a need and establishes a much-needed ETN for blood based early-AD diagnostics to address these challenges. It brings together leading academic and industrial …